Infectiologic differential diagnosis of chronic Lyme disease and so ...

More documents

Recommendations

Info

[276] Thomas NH, Collins JE, Robb SA, Robinson RO. Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child 1993; 69(5): 573-6. [277] Francis DA, Brown A, Miller DH, Wiles CM, Bennett ED, Leigh N. MRI appearances of the CNS manifestations of Mycoplasma pneumoniae: a report of two cases. J Neurol 1988; 235(7): 441-3. [278] Carstensen H, Nilsson KO. Neurological complications associated with Mycoplasma pneumoniae infection in children. Neuropediatrics 1987; 18(1): 57-8. [279] MacFarlane PI, Miller V. Transverse myelitis associated with Mycoplasma pneumoniae infection. Arch Dis Child 1984; 59(1): 80-2. [280] Foy HM, Nolan CM, Allan ID. Epidemiologic aspects of M. pneumoniae disease complications: a review. Yale J Biol Med 1983; 56(5-6): 469-73. [281] Cotter FE, Bainbridge D, Newland AC. Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange. Br Med J (Clin Res Ed) 1983; 286(6358): 22. [282] Maida E, Kristoferitsch W. Cerebrospinal fluid findings in mycoplasma pneumoniae infections with neurological complications. Acta Neurol Scand 1982; 65(5): 524-38. [283] Bayer AS, Galpin JE, Theofilopoulos AN, Guze LB. Neurological disease associated with Mycoplasma pneumoniae pneumonitis: demonstration of viable Mycoplasma pneumoniae in cerebrospinal fluid and blood by radioisotopic and immunofluorescent tissue culture techniques. Ann Intern Med 1981; 94(1): 15-20. [284] Nicholson G. Transverse myelitis complicating Mycoplasma pneumoniae infection. Postgrad Med J 1977; 53(616): 86-7. 90
[285] Mardh PA, Ursing B, Lind K. Persistent cerebellar symptoms after infection with Mycoplasma pneumoniae. Scand J Infect Dis 1975; 7(2): 157-60. [286] Hely MA, Williamson PM, Terenty TR. Neurological complications of Mycoplasma pneumoniae infection. Clin Exp Neurol 1984; 20: 153-60. [287] Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis 1993; 17 Suppl 1: S52-7. [288] Assaad F, Gispen R, Kleemola M, Syrucek L, Esteves K. Neurological diseases associated with viral and Mycoplasma pneumoniae infections. Bull World Health Organ 1980; 58(2): 297-311. [289] Lind K, Zoffmann H, Larsen SO, Jessen O. Mycoplasma pneumoniae infection associated with affection of the central nervous system. Acta Med Scnad 1979; 205(4): 325-32. [290] Fink CG, Sillis M, Read SJ, Butler L, Pike M. Neurological disease associated with Mycoplasma pneumoniae infection. PCR evidence against a direct invasive mechanism. Clin Mol Pathol 1995; 48(1): M51-4. [291] Di Maria A, Ruberto G, Redaelli C, Gualtieri G. Anterior uveitis associated with Mycoplasma pneumoniae pneumonia: a case report. Acta Ophthalmol Scand 1999; 77(3): 349-50. [292] Said MH, Layani MP, Colon S, Faraji G, Gilastre C, Cochat P. Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol 1999; 13(1): 39-44. [293] Schonwald S, Gunjaca M, Kolacny-Babic L, Car V, Gosev M. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J Antimocrob Chemother 1990; 25 Suppl A: 123-6. 91
Page 1 and 2:
Infectiologic differential diagnosi
Page 3 and 4:
3 Anamnistically, one has to consid
Page 5 and 6:
Table 2 LD coinfections (not tick-b
Page 7 and 8:
Table 5 Bartonellosis’ infection
Page 9 and 10:
Table 6 Main disease manifestations
Page 11 and 12:
11 Fig. 1. Erythrocytes infected wi
Page 13 and 14:
13 Bartonellae are localized in ery
Page 15 and 16:
ESR und CRP elevated Hypercalcemia
Page 18 and 19:
Table 9 Antibiotic treatment of bar
Page 20 and 21:
antibiosis is that the antibiotic i
Page 22 and 23:
The laboratory diagnostics for Chla
Page 24 and 25:
The arthritis occurs in 1% of the u
Page 26 and 27:
In the differential diagnosis of Ly
Page 28 and 29:
Late phase: - Reactive arthritis -
Page 30 and 31:
the depiction of chronic yersiniosi
Page 32 and 33:
In Yersinia-PCR-positive patients,
Page 34 and 35:
- Incubation period 3 weeks - Atypi
Page 36 and 37:
system, of the skin and other organ
Page 38 and 39:
- Ehrlichia chaffeensis [1] - Anapl
Page 40 and 41: Since seroprevalence merely express
Page 42 and 43: B. microti is the predominant patho
Page 44 and 45: epresent a major health hazard and
Page 46 and 47: The decisive diagnostic information
Page 48 and 49: Probable: IFA IgG 1:1024 and one of
Page 50 and 51: The main manifestation of the Campy
Page 52 and 53: The term “reactive arthritis” i
Page 54 and 55: In the diagnosis of a “reactive a
Page 56 and 57: Table 27 Disease manifestations of
Page 58 and 59: addition, other pathogens discussed
Page 60 and 61: [8] Schouls LM, Van De Pol I, Rijpk
Page 62 and 63: [25] Hermanowska-Szpakowicz T, Skot
Page 64 and 65: [43] Bakken JS, Krueth JK, Lund T,
Page 66 and 67: [60] Fox LM, Wingerter S, Ahmed A e
Page 68 and 69: [80] Marra CM. Neurologic complicat
Page 70 and 71: [100] Pulliainen AT, Dehio C. Barto
Page 72 and 73: [118] Bass JW, Freitas BC, Freitas
Page 74 and 75: [137] Gaydos CA, Roblin PM, Hammers
Page 76 and 77: [155] Cover TL, Aber RC. Yersinia e
Page 78 and 79: multi-organ donors for the presence
Page 80 and 81: [190] Straubinger RK, Straubinger A
Page 82 and 83: [208] Bitnun A, Ford-Jones E, Blase
Page 84 and 85: patients with reactive and undiffer
Page 86 and 87: [242] Appelbaum PC, Gillespie SH, B
Page 88 and 89: pneumoniae infection associated wit
Page 92 and 93: [294] File TM Jr, Segreti J, Dunbar
Page 94 and 95: [310] Sorvillo FJ, Lieb LE, Waterma
Page 96 and 97: henselae Isolates Collected from Ca
Page 98 and 99: [345] Raoult D, Levy PY, Harlé JR,
show all

Infectiologic differential diagnosis of chronic Lyme disease and so ...

Create successful ePaper yourself

Delete template?

Save as template?